Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease

NCT01066442 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
273
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Bioprojet